Abstract 3619: Nanoparticle formulation of VERU 111 for pancreatic cancer treatment
Abstract
Background: Pancreatic cancer (PanCa) is one of the leading causes of cancer-related mortality in the United States due to very limited therapeutic options. Thus, developing novel therapeutic strategies will help for the management of this disease. We recently identified VERU-111, a novel synthetic molecule which showed potent anti-cancer effect against PanCa via targeting clinically important βIII and βIV tubulin isoforms. In this study, we...
Paper Details
Title
Abstract 3619: Nanoparticle formulation of VERU 111 for pancreatic cancer treatment
Published Date
Jul 1, 2019
Journal
Volume
79
Issue
13_Supplement
Pages
3619 - 3619
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History